Phase 3 primary completion: TAR-200 in combination with Cetrelimab vs chemoradiotherapy in MIBC.
FDA catalyst calendar
Confirmed PDUFA dates, advisory committees and Phase 3 readouts. Every entry links to its primary source.
1 events · Clear filters
December 2026 1
- Dec2026
Janssen Research & Development, LLC — Cetrelimab